Home › Funds › Royce & Associates › ELAN
Royce & Associates position in ELAN
ELANCO ANIMAL HEALTH INC · Health Care
Latest position (Q1 2026)469.92K sh
Reported value held$11.25M
Portfolio Weight0.11%
First reportedQ2 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 496.93K | $7.10M | New |
| Q3 2025 | 602.56K | $12.14M | Add |
| Q4 2025 | 494.93K | $11.20M | Reduce |
| Q1 2026 | 469.92K | $11.25M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ELAN
- Dodge & Cox 67.40M sh · $1.66B · Q2 2026
- Fidelity Management & Research (FMR) 56.95M sh · $1.40B · Q2 2026
- BlackRock Inc 48.85M sh · $1.20B · Q2 2026
- Vanguard Group 48.06M sh · $1.09B · Q4 2025
- Geode Capital Management 11.30M sh · $278.20M · Q2 2026
- UBS Group AG 9.91M sh · $243.91M · Q2 2026
- Manulife Financial 8.36M sh · $205.64M · Q2 2026
- Morgan Stanley 7.85M sh · $193.30M · Q2 2026
- Invesco Ltd 5.31M sh · $130.59M · Q2 2026
- Marshall Wace 4.43M sh · $109.08M · Q2 2026
- Northern Trust Corp 4.26M sh · $104.74M · Q2 2026
- Bank of America Corp 3.91M sh · $96.22M · Q2 2026